1. Search Result

Search Result

Results for "1370448-25-1" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-137846
    PF-05221304

    Acetyl-CoA Carboxylase Inflammation/Immunology
    PF-05221304 is an orally bioavailable, liver-directed and dual ACC1 (and ACC2) inhibitor with IC50s of 7.5 nM for rat ACC1, 8.2 nM for rat ACC2, 12.4 nM for human ACC1 and 8.7 nM for human ACC2. PF-05221304 is a substrate for organic anion transport polypeptides. PF-05221304 directly improves a variety of non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) pathogenic factors.